Status:

COMPLETED

Semantic Memory, Financial Capacity, and Brain Perfusion in Mild Cognitive Impairment (MCI) (CASL)

Lead Sponsor:

VA Office of Research and Development

Collaborating Sponsors:

University of Alabama at Birmingham

Conditions:

Alzheimer Disease

Dementia

Eligibility:

All Genders

50-89 years

Brief Summary

Alzheimer's disease (AD) often manifests as a memory disorder before dementia develops. Dementia is considered to be present when a person can no longer handle complex activities of daily living, such...

Detailed Description

Alzheimer's disease (AD) often manifests as a memory disorder before dementia develops. Dementia is considered to be present when a person can no longer handle complex activities of daily living, such...

Eligibility Criteria

Inclusion

  • Veteran or non-veteran
  • Age 50-89
  • With normal cognition or memory impairment (MCI or mild AD)
  • English speaking
  • Right handed
  • Adequate vision and hearing to take part in tests
  • Able and willing to undergo MRI scan
  • Medically and psychiatrically stable
  • No other brain disease (such as tumor, Parkinson's disease, major stroke)

Exclusion

  • Pregnancy
  • Inability to tolerate MRI (due to metal in body or claustrophobia)

Key Trial Info

Start Date :

April 1 2009

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

May 1 2014

Estimated Enrollment :

78 Patients enrolled

Trial Details

Trial ID

NCT00880555

Start Date

April 1 2009

End Date

May 1 2014

Last Update

March 24 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Birmingham VA Medical Center, Birmingham, AL

Birmingham, Alabama, United States, 35233